HOUSE_OVERSIGHT_026362.jpg

1.27 MB
View Original

Extraction Summary

3
People
8
Organizations
1
Locations
2
Events
1
Relationships
3
Quotes

Document Information

Type: Email
File Size: 1.27 MB
Summary

This document is an email from Jeffrey Epstein to Sultan Bin Sulayem on July 24, 2015, discussing a new, expensive cholesterol-lowering drug called Praluent. Epstein's email is a reply to an inquiry from Sulayem, who had forwarded a Forbes article announcing the FDA's approval of the drug, which is administered as a shot.

People (3)

Name Role Context
jeffrey E. Sender
Sender of the email from jeevacation@gmail.com, replying to Sultan Bin Sulayem about a new cholesterol drug.
Sultan Bin Sulayem Recipient / Original Sender
Recipient of Jeffrey E.'s email and the sender of the original email inquiry about the cholesterol drug.
Matthew Herper Author / Journalist
Author of the forwarded Forbes article titled 'The FDA Approves A Potent And Pricey Cholesterol-Lowering Shot'.

Organizations (8)

Name Type Context
Forbes
Publisher of the article written by Matthew Herper.
Food and Drug Administration (FDA)
The U.S. government agency that approved the drug Praluent.
Regeneron Pharmaceuticals
The biotechnology company that invented the drug Praluent.
Wall Street
Mentioned in the article in the context of analysts' expectations for the cost of Praluent.
Google Plus
Social media platform mentioned in the author's bio.
Twitter
Social media platform mentioned in the author's bio.
Facebook
Social media platform mentioned in the author's bio.
HOUSE_OVERSIGHT
Likely refers to the House Oversight Committee, the source of the document as indicated by the footer.

Timeline (2 events)

2015-07-24
The FDA approved Praluent, a new cholesterol-lowering injectable drug developed by Regeneron Pharmaceuticals.
United States
2015-07-24
Email exchange between Jeffrey E. and Sultan Bin Sulayem regarding the newly approved cholesterol drug, Praluent.

Locations (1)

Location Context
Location of Regeneron Pharmaceuticals, the company that invented Praluent.

Relationships (1)

jeffrey E. Email correspondence Sultan Bin Sulayem
The document is an email chain between Jeffrey E. and Sultan Bin Sulayem on July 24, 2015.

Key Quotes (3)

"yes, it requires a shot, its not a pill and so far no long term effects known"
Source
HOUSE_OVERSIGHT_026362.jpg
Quote #1
"Have you heard of this colestrol"
Source
HOUSE_OVERSIGHT_026362.jpg
Quote #2
"The Food and Drug Administration has approved Praluent, a new medicine to lower cholesterol..."
Source
HOUSE_OVERSIGHT_026362.jpg
Quote #3

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein document